MAPT and Alzheimer disease: In particular, it has been reported that although tau contributes to both Alzheimer and Parkinson diseases, the transportation process of tau is different in these two disorders, and CNS-derived EVs carrying tau are better considered a biomarker of Parkinson’s disease than AD [165].